6:43 PM Nov 09, 2018

Alkermes adcomm reveals SPCD paradox

Disagreement between FDA and Alkermes plc on how the data were analyzed took center stage at the panel meeting on the depression drug ALKS 5461. But the meeting also flushed out a chicken-and-egg...

2:54 PM Nov 09, 2018

Cashing out CVOT

Whether or how much diabetes companies will save by dropping postmarket cardiovascular outcomes trials, if FDA follows the advice of its advisory committee, could boil down to what target they are...

11:53 AM Nov 09, 2018

Buckle-up, turbulence ahead in Washington

The midterm elections’ outcome will create deafening political noise about drug prices and great discomfort for pharmaceutical company executives. The effects on the biopharma industry will be...

8:47 PM Nov 08, 2018

HitGen’s DNA for small molecules

With more than 60 partnerships under its belt, HitGen Ltd. has become a major gateway for companies to access DNA-encoded library technology -- a high efficiency form of combinatorial chemistry...

2:41 PM Nov 08, 2018

JLABS seeks lung cancer solutions in Shanghai

As Johnson & Johnson gears up to launch its Shanghai JLABS site early next year, the incubator’s head, Sharon Chan, has pegged lung cancer as one of the first priorities.

1
2
3
4
5

Latest News

11:17 AM Nov 13, 2018

Roivant, now valued at $7B, raises $200M in equity financing

Roivant Sciences GmbH (Basel, Switzerland) raised $200 million in its fourth equity financing, which...

9:13 AM Nov 13, 2018

Dana-Farber, Deerfield launching Center for Protein Degradation

The Dana-Farber Cancer Institute and Deerfield Management partnered to create the Center for Protein...

6:42 AM Nov 13, 2018

Gottlieb announces FDA panel on opioid dosage, addiction

FDA plans to hold a new advisory committee meeting on the relationship between opioid dosage and...

4:03 AM Nov 13, 2018

Kymera raises $65M series B

Protein degradation company Kymera Therapeutics Inc. (Cambridge, Mass.) closed an untranched $65 million...

3:35 AM Nov 13, 2018

M Ventures leads $30M series A for RNA start-up Ribometrix

RNA company Ribometrix Inc. (Durham, N.C.) raised $30 million in a series A round led by M Ventures.

3:33 AM Nov 13, 2018

Hillhouse, Quan lead $93M series B for immuno-oncology play NextCure

NextCure Inc. (Beltsville, Md.) raised $93 million in a series B round led by new investors Hillhouse...

5:00 PM Nov 12, 2018

CFIUS pilot launch marks steps into biotech territory

Biotech could soon be getting more attention from the Committee of Foreign Investment in the United States...

4:38 PM Nov 12, 2018

Concert stock falls as hair loss product meets in Phase IIa, but with slower onset than Pfizer's

Concert Pharmaceuticals Inc. (NASDAQ:CNCE) lost $3.47 (22%) to $12.59 on Monday after reporting Phase IIa...

3:47 PM Nov 12, 2018

AZ’s Farxiga reduces heart failure, but misses on CV events

AstraZeneca plc (LSE:AZN; NYSE:AZN) presented details of its 17,160-patient Phase III DECLARE-TIMI 58...

3:43 PM Nov 12, 2018

Biotech starts week on sluggish note

Biotech indexes fell more than 3% on Monday, outpacing the broader market.

3:43 PM Nov 12, 2018

CStone lines up for Hong Kong IPO

With an anti-PD-L1 mAb in Phase III testing and cornerstone investors such as WuXi Ventures and Boyu...

3:00 PM Nov 12, 2018

Sequencing-based method identifies neoantigen-specific TCRs

In a Nature Biotechnology paper, researchers described a method to identify TCRs that bind to specific...

1:18 PM Nov 12, 2018

Nektar makes case for NKTR-214 optimism

On a call with investors Saturday, Nektar Therapeutics (NASDAQ:NKTR) and a PI for the Phase I/II PIVOT-2...

1:02 PM Nov 12, 2018

Harpoon raises $70M ahead of additional Phase I starts for TriTACs

Harpoon Therapeutics Inc. (South San Francisco, Calif.) raised $70 million in a series C round led by new...

12:43 PM Nov 12, 2018

Fecal transplant could treat toxicity common to checkpoint inhibitors

University of Texas MD Anderson Cancer Center researchers used fecal transplants to treat refractory...

12:37 PM Nov 12, 2018

bioMérieux grows China footprint with majority stake in Hybiome

Increasing its presence in China and the immunoassay market, France’s bioMérieux S.A. (Euronext:BIM)...

2:56 AM Nov 12, 2018

Swiss cancer play Amal eyes clinic following €21.2M tranche

Cancer vaccine company Amal Therapeutics S.A. (Geneva, Switzerland) closed the second and final tranche of...

5:39 PM Nov 09, 2018

At $500M, Moderna files to raise record IPO

mRNA company Moderna Therapeutics Inc. (Cambridge, Mass.) filed to raise $500 million in an IPO on NASDAQ,...

5:22 PM Nov 09, 2018

Investors ding Tesaro despite responses for combo in NSCLC

Tesaro Inc. (NASDAQ:TSRO) reported data Friday from the Phase I AMBER trial showing that a combination of...

5:10 PM Nov 09, 2018

June highlights shorter CAR T culture times at SITC

In a presentation at the Society for Immunotherapy of Cancer (SITC) meeting Friday, CAR T cell pioneer...

Down Up